OBJECTIVE: To measure the incidence rate and trend of acute leukemia (AL) in political districts of Mexico City. MATERIAL AND METHODS: Descriptive longitudinal study conducted at six hospitals that care for nearly 97.5% of all cancer cases among children in Mexico City. Study data were collected in 1995 and 1996, and were analyzed in 1999, at the National Medical Center "Siglo XXI" Children's Hospital, of the Mexican Institute for Social Security. Calculations of acute leukemia annual incidence rates, standardized rates, and standardized morbidity rates (SMR) with 95% confidence intervals, were obtained for each district. Morbidity trends were assessed through average change rates. RESULTS: In this study we observed an increasing trend of acute lymphoblastic leukemia (ALL) incidence in five districts: Alvaro Obregon, Cuauhtemoc, Gustavo A. Madero, Iztacalco, and Venustiano Carranza. Acute myeloblastic leukemia (AML) showed no significantly statistic increase of incidence in any district. AML did show a significant SMR in Alvaro Obregon district (SMR = 2.91, 95% CI 1.63-4.80). Higher SMRs were found in the south and southwest areas of the city. CONCLUSIONS: Increasing incidence of ALL was observed in five districts of Mexico City. AML incidence was the highest in Alvaro Obregon district.
OBJECTIVE: To measure the incidence rate and trend of acute leukemia (AL) in political districts of Mexico City. MATERIAL AND METHODS: Descriptive longitudinal study conducted at six hospitals that care for nearly 97.5% of all cancer cases among children in Mexico City. Study data were collected in 1995 and 1996, and were analyzed in 1999, at the National Medical Center "Siglo XXI" Children's Hospital, of the Mexican Institute for Social Security. Calculations of acute leukemia annual incidence rates, standardized rates, and standardized morbidity rates (SMR) with 95% confidence intervals, were obtained for each district. Morbidity trends were assessed through average change rates. RESULTS: In this study we observed an increasing trend of acute lymphoblastic leukemia (ALL) incidence in five districts: Alvaro Obregon, Cuauhtemoc, Gustavo A. Madero, Iztacalco, and Venustiano Carranza. Acute myeloblastic leukemia (AML) showed no significantly statistic increase of incidence in any district. AML did show a significant SMR in Alvaro Obregon district (SMR = 2.91, 95% CI 1.63-4.80). Higher SMRs were found in the south and southwest areas of the city. CONCLUSIONS: Increasing incidence of ALL was observed in five districts of Mexico City. AML incidence was the highest in Alvaro Obregon district.
Authors: Juan Manuel Mejía-Aranguré; Miguel Bonilla; Rodolpho Lorenzana; Servando Juárez-Ocaña; Gladys de Reyes; María Luisa Pérez-Saldivar; Guadalupe González-Miranda; Roberto Bernáldez-Ríos; Antonio Ortiz-Fernández; Manuel Ortega-Alvarez; María del Carmen Martínez-García; Arturo Fajardo-Gutiérrez Journal: BMC Cancer Date: 2005-04-04 Impact factor: 4.430
Authors: Elva Jiménez-Hernández; Arturo Fajardo-Gutiérrez; Juan Carlos Núñez-Enriquez; Jorge Alfonso Martín-Trejo; Laura Eugenia Espinoza-Hernández; Janet Flores-Lujano; José Arellano-Galindo; Aurora Medina-Sanson; Rogelio Paredes-Aguilera; Laura Elizabeth Merino-Pasaye; Martha Margarita Velázquez-Aviña; José Refugio Torres-Nava; Rosa Martha Espinosa-Elizondo; Raquel Amador-Sánchez; Juan José Dosta-Herrera; Javier Anastacio Mondragón-García; Heriberto Valdés-Guzmán; Laura Mejía-Pérez; Gilberto Espinoza-Anrubio; María Minerva Paz-Bribiesca; Perla Salcedo-Lozada; Rodolfo Ángel Landa-García; Rosario Ramírez-Colorado; Luis Hernández-Mora; María Luisa Pérez-Saldivar; Marlene Santamaría-Ascencio; Anselmo López-Loyola; Arturo Hermilo Godoy-Esquivel; Luis Ramiro García-López; Alison Ireri Anguiano-Ávalos; Karina Mora-Rico; Alejandro Castañeda-Echevarría; Roberto Rodríguez-Jiménez; José Alberto Cibrian-Cruz; Karina Anastacia Solís-Labastida; Rocío Cárdenas-Cardos; Armando Martínez-Avalos; Luz Victoria Flores-Villegas; José Gabriel Peñaloza-González; Ana Itamar González-Ávila; Martha Beatriz Altamirano-García; Norma López-Santiago; Martin Sánchez-Ruiz; Roberto Rivera-Luna; Luis Rodolfo Rodríguez-Villalobos; Francisco Hernández-Pérez; Jaime Ángel Olvera-Durán; Luis Rey García-Cortés; Minerva Mata-Rocha; Omar Alejandro Sepúlveda-Robles; Cesar Raúl González-Bonilla; Vilma Carolina Bekker-Méndez; Silvia Jiménez-Morales; Haydee Rosas-Vargas; Juan Manuel Mejía-Aranguré Journal: Cancer Med Date: 2018-03-13 Impact factor: 4.452
Authors: Gabriela Antonio-Andres; Gustavo U Martinez-Ruiz; Mario Morales-Martinez; Elva Jiménez-Hernandez; Estefany Martinez-Torres; Tania V Lopez-Perez; Laura A Estrada-Abreo; Genaro Patino-Lopez; Sergio Juarez-Mendez; Víctor M Davila-Borja; Sara Huerta-Yepez Journal: Int J Mol Sci Date: 2022-02-02 Impact factor: 5.923
Authors: Janet Flores-Lujano; David Aldebarán Duarte-Rodríguez; Elva Jiménez-Hernández; Jorge Alfonso Martín-Trejo; Aldo Allende-López; José Gabriel Peñaloza-González; María Luisa Pérez-Saldivar; Aurora Medina-Sanson; José Refugio Torres-Nava; Karina Anastacia Solís-Labastida; Luz Victoria Flores-Villegas; Rosa Martha Espinosa-Elizondo; Raquel Amador-Sánchez; Martha Margarita Velázquez-Aviña; Laura Elizabeth Merino-Pasaye; Nora Nancy Núñez-Villegas; Ana Itamar González-Ávila; María de Los Ángeles Del Campo-Martínez; Martha Alvarado-Ibarra; Vilma Carolina Bekker-Méndez; Rocío Cárdenas-Cardos; Silvia Jiménez-Morales; Roberto Rivera-Luna; Haydee Rosas-Vargas; Norma C López-Santiago; Angélica Rangel-López; Alfredo Hidalgo-Miranda; Elizabeth Vega; Minerva Mata-Rocha; Omar Alejandro Sepúlveda-Robles; José Arellano-Galindo; Juan Carlos Núñez-Enríquez; Juan Manuel Mejía-Aranguré Journal: Front Public Health Date: 2022-09-14
Authors: Maria Luisa Perez-Saldivar; Manuel Carlos Ortega-Alvarez; Arturo Fajardo-Gutierrez; Roberto Bernaldez-Rios; Maria de Los Angeles Del Campo-Martinez; Aurora Medina-Sanson; Miguel Angel Palomo-Colli; Rogelio Paredes-Aguilera; Armando Martínez-Avalos; Victor Hugo Borja-Aburto; Maria de Jesus Rodriguez-Rivera; Victor Manuel Vargas-Garcia; Jesus Zarco-Contreras; Janet Flores-Lujano; Juan Manuel Mejia-Arangure Journal: BMC Cancer Date: 2008-01-14 Impact factor: 4.430